0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R1,000 - R2,500 (1)
  • R2,500 - R5,000 (1)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Paperback, New ed.):... Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Paperback, New ed.)
Kenneth C. Shadlen, Samira Guennif, Alenka Guzman, Narayanan Lalitha
R1,250 Discovery Miles 12 500 Ships in 12 - 17 working days

'Since the 1970s the pharmaceutical industry has undergone significant changes in its research and development paradigm, trade and production. Regulatory frameworks have also changed substantially, particularly in the area of intellectual property rights. This book provides much needed empirical evidence on the impact of these and other changes on the pharmaceutical sector and on access to medicines in developing countries. The studies, conducted with a common methodology, on nine developing countries (including major producers of pharmaceuticals such as China and India) and on Canada, make an outstanding contribution to the literature in the field. The data and analysis in the book are of immediate interest to policy makers and to scholars in various fields, including innovation economics, industrial policy, health systems and intellectual property.' - Carlos Correa, University of Buenos Aires, Argentina This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Hardcover): Kenneth C.... Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Hardcover)
Kenneth C. Shadlen, Samira Guennif, Alenka Guzman, Narayanan Lalitha
R3,838 Discovery Miles 38 380 Ships in 12 - 17 working days

'Since the 1970s the pharmaceutical industry has undergone significant changes in its research and development paradigm, trade and production. Regulatory frameworks have also changed substantially, particularly in the area of intellectual property rights. This book provides much needed empirical evidence on the impact of these and other changes on the pharmaceutical sector and on access to medicines in developing countries. The studies, conducted with a common methodology, on nine developing countries (including major producers of pharmaceuticals such as China and India) and on Canada, make an outstanding contribution to the literature in the field. The data and analysis in the book are of immediate interest to policy makers and to scholars in various fields, including innovation economics, industrial policy, health systems and intellectual property.' - Carlos Correa, University of Buenos Aires, Argentina This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Loot
Nadine Gordimer Paperback  (2)
R205 R164 Discovery Miles 1 640
Loot
Nadine Gordimer Paperback  (2)
R205 R164 Discovery Miles 1 640
With God All Things Are Possible Small…
Paperback R35 R29 Discovery Miles 290
Marco Prestige Laptop Bag (Black)
R676 Discovery Miles 6 760
Loot
Nadine Gordimer Paperback  (2)
R205 R164 Discovery Miles 1 640
Wonder Plant Food Stix - Premium Plant…
R49 R41 Discovery Miles 410
Casio LW-200-7AV Watch with 10-Year…
R999 R884 Discovery Miles 8 840
Bostik Clear in Box (25ml)
R26 Discovery Miles 260
Alcolin Cold Glue (500ml)
R128 R99 Discovery Miles 990
Rogz Indoor 3D Pod Dog Bed (Petrol/Grey…
R1,775 Discovery Miles 17 750

 

Partners